PCV29 Economic and healthcare impact of lung perfusion scintigraphy in diagnosis of subjects with a suspect of acute pulmonary embolism

2021 ◽  
Vol 24 ◽  
pp. S72
Author(s):  
C.G. Leo ◽  
P. Mincarone ◽  
P. Mammucci ◽  
A.R. Pisani ◽  
C. Ferrari ◽  
...  
Keyword(s):  
Pulmonary Embolism ◽  
Acute Pulmonary Embolism ◽  
Lung Perfusion ◽  
Perfusion Scintigraphy ◽  
Lung Perfusion Scintigraphy

scholarly journals Healthcare and Economic Impact of Lung Perfusion Scintigraphy in Patients Affected by Acute Pulmonary Embolism

Healthcare ◽  
2021 ◽  
Vol 9 (6) ◽  
pp. 716
Author(s):  
Giuseppe Rubini ◽  
Cristina Ferrari ◽  
Paolo Mammucci ◽  
Antonio Pisani ◽  
Pierpaolo Mincarone ◽  
...  
Keyword(s):  
Pulmonary Embolism ◽  
Acute Pulmonary Embolism ◽  
Pulmonary Angiography ◽  
Lung Perfusion ◽  
Perfusion Scintigraphy ◽  
Lung Perfusion Scintigraphy ◽  
Assessment And Treatment ◽  
Risk Patients ◽  
Direct Healthcare Costs ◽  
Healthcare Processes

Acute pulmonary embolism (APE) is a cardiovascular emergency, representing the main cause of mortality, morbidity, and hospitalisation in Europe. We aim to evaluate the economic and healthcare impact of lung perfusion scintigraphy (LPS) used in patients with suspected APE, in the event of non-conclusive or contraindicated computed tomography pulmonary angiography (CTPA). We considered two alternative healthcare processes for APE diagnosis, with and without LPS. We performed a cost analysis with the aim of evaluating the average direct healthcare costs for diagnosis, risk assessment, and treatment of APE. We used data from a monocentric trial. Our economic model showed that the strategy with LPS was preferable in terms of costs. The average per-patient costs for the diagnosis and treatment of the acute phase of PE in low-risk patients with a non-conclusive or not-executable CTPA, with and without LPS, are EUR 2145.25 and EUR 4912.45, respectively. LPS is a simple, quick, and economic examination, useful in this setting of patients not only for an early diagnosis but also to exclude APE, demonstrating an advantage in terms of healthcare resources. To the best of our knowledge, this study is the first to analyse the economic and healthcare impact of the use of LPS in the diagnostic pathway of suspected APE.

scholarly journals Pulmonary embolism as post-COVID-19 sequelae: Role of lung perfusion scintigraphy

2021 ◽  
Vol 36 (4) ◽  
pp. 455
Author(s):  
Priyanka Verma ◽  
Keerti Sitani ◽  
RameshD Rao ◽  
Ashok Chandak ◽  
RameshV Asopa
Keyword(s):  
Pulmonary Embolism ◽  
Lung Perfusion ◽  
Perfusion Scintigraphy ◽  
Lung Perfusion Scintigraphy

scholarly journals The Utility of Hybrid SPECT/CT Lung Perfusion Scintigraphy in Pulmonary Embolism Diagnosis

Respiration ◽  
2015 ◽  
Vol 90 (5) ◽  
pp. 393-401 ◽  
Author(s):  
Andrzej Mazurek ◽  
Miroslaw Dziuk ◽  
Ewa Witkowska-Patena ◽  
Stanislaw Piszczek ◽  
Agnieszka Gizewska
Keyword(s):  
Pulmonary Embolism ◽  
Lung Perfusion ◽  
Perfusion Scintigraphy ◽  
Lung Perfusion Scintigraphy ◽  
Pulmonary Embolism Diagnosis

COMPARISON OFDUAL ENERGY CT LUNG PERFUSION VERSUS LUNG VENTILATION/PERFUSION SCINTIGRAPHY IN PULMONARY EMBOLISM

2020 ◽  
Vol 71 (2) ◽  
pp. 399-410
Author(s):  
Khaled Abdelghany ◽  
Noha Osman ◽  
Eman Geneidi ◽  
Hala Abou Senna ◽  
Ahmed Nasr ◽  
...  
Keyword(s):  
Pulmonary Embolism ◽  
Lung Ventilation ◽  
Lung Perfusion ◽  
Perfusion Scintigraphy
Sign in / Sign up

Export Citation Format

Share Document